AC
GILD icon

Alexandria Capital’s Gilead Sciences GILD Stock Holding History

Alexandria Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-260
Closed -$21K – 346
2017
Q3 		$21K Hold
260
– – 0.01% 347
2017
Q2 		$18K Buy
+260
New +$17.3K ﹤0.01% 358
2017
Q1 		– Sell
-72,162
Closed -$5.17M – 622
2016
Q4 		$5.17M Sell
72,162
-80,092
-53% -$5.95M 1.33% 23
2016
Q3 		$12M Sell
152,254
-7,975
-5% -$648K 2.22% 11
2016
Q2 		$13.4M Buy
160,229
+2,555
+2% +$227K 2.38% 9
2016
Q1 		$14.5M Buy
157,674
+92,226
+141% +$8.32M 2.6% 7
2015
Q4 		$6.62M Sell
65,448
-12,416
-16% -$1.29M 1.66% 17
2015
Q3 		$7.65M Sell
77,864
-390
-0.5% -$43.3K 1.86% 13
2015
Q2 		$9.18M Buy
78,254
+78,127
+61,517% +$8.54M 2.04% 12
2015
Q1 		$12K Buy
127
+50
+65% +$5.08K ﹤0.01% 369
2014
Q4 		$7K Hold
77
– – ﹤0.01% 414
2014
Q3 		$8K Sell
77
-13
-14% -$1.27K ﹤0.01% 371
2014
Q2 		$7K Sell
90
-79
-47% -$6.15K ﹤0.01% 399
2014
Q1 		$12K Hold
169
– – 0.01% 339
2013
Q4 		$13K Hold
169
– – 0.01% 332
2013
Q3 		$11K Sell
169
-6
-3% -$359 0.01% 353
2013
Q2 		$9K Buy
+175
New +$9.12K ﹤0.01% 391

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alexandria Capital's GILD Position: Q4 2017 in Review

Alexandria Capital sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 260 shares — an estimated $21K sold.

Alexandria Capital first reported a position in GILD in Q2 2013 and held it in 17 quarters. The position peaked at $14.5M in Q1 2016. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Alexandria Capital reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • Alexandria Capital sold 260 Gilead Sciences shares in Q4 2017, an estimated $21K.
  • Alexandria Capital first reported a position in Gilead Sciences in Q2 2013 and held it in 17 quarters.
  • Alexandria Capital's Gilead Sciences position peaked at $14.5M in Q1 2016.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Alexandria Capital's 13F filing for Q4 2017, filed 9 Feb 2018.